Current conservation status of the Blue Swallow Hirundo atrocaerulea Sundevall 1850 in Africa

The global Blue Swallow Hirundo atrocaerulea was classified as Vulnerable in 2010 on account of its small and rapidly declining population estimated at less than 1 500 pairs. We undertook this study to gain a better  understanding of the current status and threats facing this migratory species. Three previously unknown areas that might be part of the species’ non-breeding range were identified in Kenya and northern Tanzania. Within its breeding range we identified three previously unknown areas of potentially suitable habitat, one in Tanzania and two in Malawi, which require further exploration. Population viability assessment predicted that the Blue Swallow population will decline by 8% in 10 years. The overall probability of extinction of the species in the wild is 3%. Minimum viable population size analysis suggests that a goal for the long-term conservation of the Blue Swallow should be to mitigate current threats that are driving declines such that the population increases to a minimum of 3 600 individuals. This should consist of at least 900 individuals in each of the four clusters identified, along with a minimum of 500 individuals in at least one of the meta-populations per cluster. The four clusters are located in (1) the southeasten Democratic Republic of the Congo, (2) highlands of southern Tanzania and northern Malawi, (3) eastern highlands of Zimbabwe and (4) South Africa and Swaziland. The current proportions of the Blue Swallow population in strictly protected and unprotected areas on their breeding grounds are 53% and 47%, respectively, whereas on their non-breeding grounds the corresponding percentages are 25% and 75%, respectively. Our reassessment of the Blue Swallow’s risk of extinction indicates that it continues to qualify as Vulnerable according to the IUCN/SSC criteria C2a(i).Keywords: Blue Swallow, conservation recommendations, conservation status, distribution, Hirundinidae, minimum viable population size, population viability, species distribution modelling, threat

The healing of a Canaanite woman's daughter (Matthew 15:21-28)

story of a Canaanite woman is complicated, because it contains Jesus' initial harsh attitude towards this woman. This story has led to some scholars assuming that Matthew is a Jewish document and the community behind it was a kind of Christian Judaism, not actively involved in the Gentile mission. However, from the literary point, this story contains several literary devices to highlight Jesus' dramatic healing of a Gentile patient. Jesus' initial responses are exactly what the contemporaries would expect of a rabbi. However, Jesus, like a wise teacher who uses a tactic to give an impressive teaching, expressed his reluctance to heal. The whole pericope functions as an intentional demonstration that Jesus did expand his ministry to a Gentile patienthttp://search.sabinet.co.za/WebZ/Authorize?sessionid=0&next=ej/ej_content_patris.html&bad=error/authofail.htm

Rifamycin antibiotic resistance by ADP-ribosylation: Structure and diversity of Arr

The rifamycin antibiotic rifampin is important for the treatment of tuberculosis and infections caused by multidrug-resistant Staphylococcus aureus. Recent iterations of the rifampin core structure have resulted in new drugs and drug candidates for the treatment of a much broader range of infectious diseases. This expanded use of rifamycin antibiotics has the potential to select for increased resistance. One poorly characterized mechanism of resistance is through Arr enzymes that catalyze ADP-ribosylation of rifamycins. We find that genes encoding predicted Arr enzymes are widely distributed in the genomes of pathogenic and nonpathogenic bacteria. Biochemical analysis of three representative Arr enzymes from environmental and pathogenic bacterial sources shows that these have equally efficient drug resistance capacity in vitro and in vivo. The 3D structure of one of these orthologues from Mycobacterium smegmatis was determined and reveals structural homology with ADP-ribosyltransferases important in eukaryotic biology, including poly(ADP-ribose) polymerases (PARPs) and bacterial toxins, despite no significant amino acid sequence homology with these proteins. This work highlights the extent of the rifamycin resistome in microbial genera with the potential to negatively impact the expanded use of this class of antibiotic